CN105055771A - Chinese herbal medicament for treating coronary heart disease - Google Patents
Chinese herbal medicament for treating coronary heart disease Download PDFInfo
- Publication number
- CN105055771A CN105055771A CN201510460095.XA CN201510460095A CN105055771A CN 105055771 A CN105055771 A CN 105055771A CN 201510460095 A CN201510460095 A CN 201510460095A CN 105055771 A CN105055771 A CN 105055771A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart disease
- coronary heart
- pain
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese herbal medicament for treating coronary heart disease, prepared from, by weight, 2 parts of musk, 2 parts of storax, 1 part of borneol, 1 part of toad venom, 9 parts of safflower, 4 parts of white sandalwood, 2 parts of bezoar, 9 parts of ginseng, 14 parts of wolfberry fruit, 30 parts of common yam rhizome, and 1 part of rhino horn. The medicinal materials, the musk used for inducing resuscitation, activating blood flow and reliving swelling and pain, the storax used for dredging apertures and organs to dispel all bad qi, the borneol used for inducing resuscitation and clearing internal heat to stop pain, the toad venom used for detoxifying and stopping pain and inducing resuscitation, the safflower used for activating blood flow and dissipating blood stasis to stop pain, the white sandalwood used for promoting the circulation of qi to warm the middle warmer, the bezoar used for clearing heart-fire and eliminating phlegm, the ginseng used for reinforcing vital energy and restoring pulse to relieve depletion, the wolfberry fruit used for nourishing liver and kidney and replenishing essence to improve vision, the common ham rhizome cool in property and wet and used for reinforcing kidney to boost essence, the rhino horn used for clearing internal heat to cool blood, are combined to be effective in tonifying kidney, regulating mental activities and promoting blood and qi circulation. Clinical testing shows that the Chinese herbal medicament is safe and effective in treating coronary heart disease.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine being used for the treatment of coronary heart disease.
Background technology
Coronary heart disease is one of person in middle and old age's commonly encountered diseases, and in every country, death rate of the onset is also higher, and its pathological tissues shows as endarterium lipid calmness, thickens formation speckle.Speckle expands gradually, and both central necrotic, softening, disintegrate, be mixed into atheromatous plaque focus with lipid.The atheromatous plaque increased makes arterial lumen narrow gradually, blocks, and hinders coronary blood to flow through.Coronary heart disease is apt to occur in the male of more than 45 years old, more than 55 years old or postclimacteric women, and sickness rate rises just year by year in recent years, and has the trend become younger.
Bring out during this onste or because of physical exertion, excited etc., prominent sense precordialgia, mostly be ictal angor or squeezing pain, also can be sense of feeling oppressed.Pain, from after breastbone or pareordia, is upwards radiated to left shoulder, arm, even little finger of toe and the third finger.The position that chest pain is diffused also can relate to cervical region, lower jaw, tooth, abdominal part etc.Under chest pain also can appear at rest state or night, caused by coronary spasm.If aggravation, the patient threshold of pain progressively declines so that pause physical exertion or excited even have a rest or sleep soundly Shi Yike outbreak.Pain is aggravated gradually, frequency conversion, duration extension.
The method of current western medical treatment coronary heart disease comprises Drug therapy and operative treatment
1, Drug therapy: antithrombotic (antiplatelet, anticoagulant), alleviates myocardium keto consumption (beta-blocker), allevating angina pectoris (nitrate esters), adjusts fat stabilize plaque (Statins fat regulation medicine);
2, operative treatment comprises interventional therapy (intravascular balloon expansion plasty and Stent) and surgery coronary artery bypass grafting.
Easily there is the complication such as hepatic and renal function injure, drug dependence and ventricular aneurysm, mitral incompetence, perforation of ventricular septum in the Therapeutic Method patient of doctor trained in Western medicine.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of Chinese medicine being used for the treatment of coronary heart disease, by selecting suitable medical material and proportioning thereof, reaches the object of safe and effective healing coronary heart disease.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of Chinese medicine being used for the treatment of coronary heart disease; it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: 2 parts, Moschus, Styrax 2 parts, Borneolum Syntheticum 1 part, Venenum Bufonis 1 part, 9 parts, Flos Carthami, Santalum album 4 parts, Calculus Bovis 2 parts, Radix Ginseng 9 parts, Fructus Lycii 14 parts, Rhizoma Dioscoreae 30 parts, Cornu rhinocerotis 1 part.
Inventor thinks, the human heart five elements return fire to belong to sun, and fire of moxibustion crosses prosperous and even internal organs hypertrophy, and heart tube wall is thickening makes angiostenosis.The main water of kidney belongs to cloudy, water FT-207 fire.Deficiency of the kidney yin and heart-yang declines, therefore the kidney invigorating regulation of mental activities, YIN nourishing drives sun.
The present invention uses:
Moschus: refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain; Styrax: can saturating all keys dirty, ward off all not gas just; Borneolum Syntheticum: refreshment of having one's ideas straightened out, clearing away heat to alleviate pain; Venenum Bufonis: removing toxic substances pain relieving, refreshment of having one's ideas straightened out; Flos Carthami: promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain; Santalum album: circulation of qi promoting warming middle-JIAO; Calculus Bovis: clearing away heart-fire and eliminating phlegm; Radix Ginseng: strongly invigorating primordial QI, multiple arteries and veins takes off admittedly; Fructus Lycii: nourishing the liver and kidney, replenishing vital essence to improve eyesight; Rhizoma Dioscoreae: cool in nature and moisten, benefit of reinforcing the kidney essence; Cornu rhinocerotis: clearing away heat and cooling blood.
All medicines share, and play the kidney invigorating regulation of mental activities altogether, and effect of blood-activating and qi-promoting, effectively treats coronary heart disease.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects patients with coronary heart disease 80 example for 2012 altogether between year December of December ~ 2014, all from Cardiological outpatient service, men and women half and half, 45 ~ 60 years old age, man 38 example, female 42 example.The course of disease 3 months ~ 5 years.
Coronary artery lesions classification:
Anginal classification: generally adopt cardiovascular association of CCSC Canada staging in the world.
I level: daily routines, as walking, cat ladder, without angina pectoris attacks.
II level: daily routines are slightly limited because of angina pectoris.
III grade: daily routines are obviously limited because of angina pectoris attacks.
IV grade: any physical exertion all can cause angina pectoris attacks.
Wherein II level patient 67 people.III grade of patient 10 people.IV grade of patient 3 people.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Hepatic and renal function is abnormal or with serious primary disease etc.
2, test method
The capsule that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.6 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " Angina evaluation criteria ".
1. effective: after exertional angina pectoris treatment, angina pectoris symptom classification reduces two-stage.Originally be that I, II level person angina pectoris disappears (namely also substantially not occurring angina pectoris in the heavier physical exertion exceeding daily routines) substantially.Without nitroglycerin.Noneffort angina transference cure or substantially disappear, angina pectoris attacks is no more than secondary weekly, substantially without nitroglycerin.
2. improve: after exertional angina pectoris treatment, angina pectoris symptom reduces I level, and nitroglycerin subtracts with over half.Originally be that I level person angina pectoris disappears, substantially without nitroglycerin.After noneffort angina treatment, angina pectoris number of times, nitroglycerin consumption reduce over half.
3. substantially invalid: symptom and nitroglycerin consumption, without change, though reduce to some extent, do not reach improvement degree.
4. increase the weight of: panic attacks number of times, degree and persistent period increase the weight of, or angina pectoris upgrading, nitroglycerin consumption increases
3.2 therapeutic outcome
Effective 62 examples of 80 routine patients, improve 14 examples, and substantially invalid 4 examples, increase the weight of 0 example.Total effective rate 95%.There is laxativeness in treatments period 2 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of coronary heart disease, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: 2 grams, Moschus, Styrax 2 grams, Borneolum Syntheticum 1 gram, Venenum Bufonis 1 gram, 9 grams, Flos Carthami, Santalum album 4 grams, Calculus Bovis 2 grams, Cornu rhinocerotis 1 gram, be ground into fine powder altogether, obtain product A; Take: Radix Ginseng 9 grams, Fructus Lycii 14 grams, Rhizoma Dioscoreae 30 grams, add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, pulverize into fine powder, then adds product A, mixing; Incapsulate shell, the capsule of adult normal's one day consumption must be met.
Be used for the treatment of coronary heart disease.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. one kind is used for the treatment of the Chinese medicine of coronary heart disease; it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: 2 parts, Moschus, Styrax 2 parts, Borneolum Syntheticum 1 part, Venenum Bufonis 1 part, 9 parts, Flos Carthami, Santalum album 4 parts, Calculus Bovis 2 parts, Radix Ginseng 9 parts, Fructus Lycii 14 parts, Rhizoma Dioscoreae 30 parts, Cornu rhinocerotis 1 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510460095.XA CN105055771A (en) | 2015-07-30 | 2015-07-30 | Chinese herbal medicament for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510460095.XA CN105055771A (en) | 2015-07-30 | 2015-07-30 | Chinese herbal medicament for treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105055771A true CN105055771A (en) | 2015-11-18 |
Family
ID=54485448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510460095.XA Pending CN105055771A (en) | 2015-07-30 | 2015-07-30 | Chinese herbal medicament for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055771A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939410A (en) * | 2005-06-17 | 2007-04-04 | 吕宝俊 | Musk medicinal preparation |
| JP2010171924A (en) * | 2009-01-26 | 2010-08-05 | Toshiba Corp | Image reader, image forming apparatus and foreign substance detection method of image reader |
-
2015
- 2015-07-30 CN CN201510460095.XA patent/CN105055771A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1939410A (en) * | 2005-06-17 | 2007-04-04 | 吕宝俊 | Musk medicinal preparation |
| JP2010171924A (en) * | 2009-01-26 | 2010-08-05 | Toshiba Corp | Image reader, image forming apparatus and foreign substance detection method of image reader |
Non-Patent Citations (3)
| Title |
|---|
| 国务院: "中国人民共和国野生动物保护法", 《中华人民共和国国务院公报》 * |
| 国发[1993]39号: "国务院关于禁止犀牛角和虎骨贸易的通知", 《中华人民共和国国务院公报》 * |
| 王振华等: "大力救心丹治疗冠心病心绞痛100例疗效观察", 《中国中医急症》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101564521B (en) | External plaster for treating hyperplasia of mammary glands | |
| CN105194565A (en) | Traditional Chinese medicine pills for treatment of cardiac neurosis and preparation method thereof | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN105169214A (en) | Traditional Chinese medicine composition for treating atherosclerosis, and preparation method thereof | |
| CN105596777A (en) | Traditional Chinese medicine for dredging blood vessels and reducing blood pressure | |
| CN102441154B (en) | A kind of Chinese medicine preparation for the treatment of gout | |
| CN104758353A (en) | Medicine composition for treating cardiovascular diseases, preparation method and application thereof | |
| CN104069446A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN103893670A (en) | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases | |
| CN103071115B (en) | Traditional Chinese medicine preparation for treating coronary sclerosis | |
| CN104147346A (en) | Traditional Chinese medicinal compound for treating coronary diffuse lesion angina | |
| CN104432386B (en) | A kind ofly prevent and treat soreness and weakness of waist and knees, parasitic loranthus oral liquid that muscles and bones is unable and preparation method thereof | |
| CN103316217B (en) | Traditional Chinese medicine preparation for treating heart diseases and preparation method therefor | |
| CN105055771A (en) | Chinese herbal medicament for treating coronary heart disease | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104623057A (en) | Pharmaceutical composition for treating diabetic feet and application pf pharmaceutical composition | |
| CN109646483A (en) | A kind of Chinese medicine bathing antibacterial liquid/particle improving blood stasis constitution and preparation and application method | |
| CN105582303A (en) | Traditional Chinese medicine preparation for treating coronary heart disease | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN105030993A (en) | Chinese medicine compound, toxin expelling liquid and preparation method of toxin expelling liquid | |
| CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN103463474B (en) | Traditional Chinese medicinal composition for treating chronic heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151118 |